4.8 Article

N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis

Journal

NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-29125-7

Keywords

-

Funding

  1. National Natural Science Foundation of China [81922052, 81974435, 82002981]
  2. Natural Science Foundation of Guangdong Province [2019B151502011]
  3. Guangzhou People's Livelihood Science and Technology Project [201903010006]
  4. National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [NRF-2020R1C1C1009842, NRF-2020R1A4A1018398]

Ask authors/readers for more resources

This study reveals the oncogenic function of mis-regulated tRNA modification in esophageal squamous cell carcinoma (ESCC) and suggests that targeting METTL1 and its downstream signaling could be a promising therapeutic strategy for ESCC treatment.
Deregulation of METTL1-mediated N7- methylguanosine tRNA modification can promote oncogenesis. Here, the authors report that this modification regulates the translation of proteins in both the mTOR and negative regulators of autophagy pathways, resulting in the progression of esophageal squamous cell carcinoma. Mis-regulated RNA modifications promote the processing and translation of oncogenic mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear. Here we reveal that tRNA m(7)G methyltransferase complex proteins METTL1 and WDR4 are significantly up-regulated in esophageal squamous cell carcinoma (ESCC) tissues and associated with poor ESCC prognosis. In addition, METTL1 and WDR4 promote ESCC progression via the tRNA m(7)G methyltransferase activity in vitro and in vivo. Mechanistically, METTL1 or WDR4 knockdown leads to decreased expression of m(7)G-modified tRNAs and reduces the translation of a subset of oncogenic transcripts enriched in RPTOR/ULK1/autophagy pathway. Furthermore, ESCC models using Mettl1 conditional knockout and knockin mice uncover the essential function of METTL1 in promoting ESCC tumorigenesis in vivo. Our study demonstrates the important oncogenic function of mis-regulated tRNA m(7)G modification in ESCC, and suggest that targeting METTL1 and its downstream signaling axis could be a promising therapeutic target for ESCC treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

Ganping Wang, Yarong Dai, Kang Li, Maosheng Cheng, Gan Xiong, Xiaochen Wang, Shuang Chen, Zhi Chen, Jianwen Chen, Xiuyun Xu, Rong-song Ling, Liang Peng, Demeng Chen

Summary: The study demonstrates that Mettl3-mediated m(6)A modification is crucial for the activation of TEK-VEGF-A-mediated tumor progression and angiogenesis in bladder cancer. Experimental results using transgenic mouse models and bladder cancer stem cell populations showed that depletion of Mettl3 inhibits tumor oncogenesis and progression in bladder cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell & Tissue Engineering

METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway

Yu Liang, Hui Han, Qiuchan Xiong, Chunlong Yang, Lu Wang, Jieyi Ma, Shuibin Lin, Yi-Zhou Jiang

Summary: Knockout of METTL3 in muscle stem cells inhibits cell proliferation and blocks muscle regeneration, while knockin of METTL3 promotes cell proliferation and regeneration. The METTL3-m(6)A-YTHDF1 axis regulates Notch signaling pathway mRNA translation, revealing the important physiological role of METTL3-mediated m(6)A modification in muscle stem cells and regeneration.

STEM CELLS INTERNATIONAL (2021)

Editorial Material Biotechnology & Applied Microbiology

RNA epitranscriptomics: A promising new avenue for cancer therapy

Chunlong Yang, Hui Han, Shuibin Lin

MOLECULAR THERAPY (2022)

Editorial Material Cell Biology

N7-methylguanosine (m7G) tRNA modification: a novel autophagy modulator in cancer

Hui Han, Siyi Zheng, Shuibin Lin

Summary: METTL1 and WDR4 act as negative regulators of autophagy in esophageal squamous cell carcinoma (ESCC) by modulating the MTORC1-mediated autophagy signaling pathway, leading to cell death and poor prognosis in ESCC.

AUTOPHAGY (2023)

Review Oncology

N6-methyladenosine (m6A) RNA modification in tumor immunity

Siyi Zheng, Hui Han, Shuibin Lin

Summary: Growing evidence suggests that the progression of cancer is closely linked to the tumor microenvironment and evasion of the immune system. Recent studies have highlighted the important roles of epigenetic regulators, particularly N-6-methyladenosine (m(6)A) modification, in shaping the tumor microenvironment and restoring immune recognition. These modifications have significant effects on various biological processes, including tumorigenesis and progression. Additionally, abnormal m(6)A modification has been found to play critical functions in regulating tumor immunity.

CANCER BIOLOGY & MEDICINE (2022)

Article Oncology

METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation

Ying Huang, Jieyi Ma, Cuiyun Yang, Paijia Wei, Minghui Yang, Hui Han, Hua Dong Chen, Tianfang Yue, Shu Xiao, Xuanyu Chen, Zuoqing Li, Yanlai Tang, Jiesi Luo, Shuibin Lin, Libin Huang

Summary: This study identified the critical role and mechanism of METTL1-mediated tRNA m(7)G modification in regulating NBL progression, providing new insights for developing therapeutic approaches for NBL patients. The up-regulation of METTL1 in advanced NBL was found to be an independent risk factor predicting poor prognosis. METTL1 played a crucial role in promoting NBL progression, with downregulation inhibiting puromycin intake efficiency and impacting gene translation efficiency in oncogenic pathways.

BIOMARKER RESEARCH (2022)

Article Cell Biology

Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC

Chunlong Yang, Xiaoning Cheng, Shenglan Gao, Qingjun Pan

Summary: This study focuses on the elusive role of endothelial cells in the tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC). By using advanced single-cell RNA sequencing technology, the authors identify different subtypes of endothelial cells and construct a prognostic risk model for HNSCC. The findings provide insights into the heterogeneity of the TME at the single-cell level and offer a prognostic model for HNSCC patients.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Article Endocrinology & Metabolism

N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation

Hao Peng, Binbin Chen, Wei Wei, Siyao Guo, Hui Han, Chunlong Yang, Jieyi Ma, Lu Wang, Sui Peng, Ming Kuang, Shuibin Lin

Summary: This study reveals the regulatory role of 18S rRNA modifications in cancer progression and prognosis, particularly in hepatocellular carcinoma. The findings demonstrate the critical functions of METTL5 in promoting HCC tumorigenesis through impaired ribosome assembly and decreased translation of fatty acid metabolism genes. The study also highlights the potential therapeutic strategies targeting METTL5 and ACSL4 for HCC treatment.

NATURE METABOLISM (2022)

Article Biochemistry & Molecular Biology

Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function

Lu Wang, Yu Liang, Rongzhi Lin, Qiuchan Xiong, Peng Yu, Jieyi Ma, Maosheng Cheng, Hui Han, Xiaochen Wang, Ganping Wang, Fengyin Liang, Zhong Pei, Demeng Chen, Quan Yuan, Yi-Zhou Jiang, Shuibin Lin

Summary: METTL5 protein regulates brain function and intelligence by controlling rRNA modification, and Mettl5 knockout results in intellectual disability and abnormal nervous development.

GENES & DISEASES (2022)

No Data Available